Sephalin SRL
0.2 FTEThe score of Sephalin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +109 % Total assets -5 % Headcount (avg FTE) -75 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sephalin's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Sephalin's financial analysis
- Solvency28.2%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sephalin
Sephalin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0712.968.905
- VAT number
- BE0712968905
- Peppol
- Registered · 0208:0712968905 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Nov 2018
- Registered office
- 8630 Veurne
- Size
- Micro · 0.2 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sephalin (SRL) has been based in Veurne since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 94,283 € and equity of 449,274 €; its revenue is not published. With 0.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 28.2%, below the median of its sector (44.0%).
Companies similar to Sephalin
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Vanderhaeghen Retail sale of pharmaceutical products Lievegem · balance sheet €1.58m
- Sibilia Retail sale of pharmaceutical products Grimbergen · balance sheet €1.62m
- Lenans Retail sale of pharmaceutical products Mons · balance sheet €1.57m
- Farma Koersel Retail sale of pharmaceutical products Beringen · balance sheet €1.63m
- Youken Company Retail sale of pharmaceutical products Frameries · balance sheet €1.64m
- VVM Pharma Invest Retail sale of pharmaceutical products Waregem · balance sheet €1.66m
- PCMA Retail sale of pharmaceutical products Chaudfontaine · balance sheet €1.53m
Frequently asked questions about Sephalin
What is the revenue of Sephalin?
Sephalin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sephalin?
In Belgium, the VAT number is the company number prefixed with BE: BE0712968905 for Sephalin, if the company is VAT-registered. Its company number (CBE) is 0712.968.905.
Where is the registered office of Sephalin?
According to the CBE register, the registered office of Sephalin is in 8630 Veurne.
What is the equity of Sephalin?
At the close of the 2025 financial year, the equity of Sephalin amounts to 449,274 €, a solvency of 28.2% of total assets.
How many people work at Sephalin?
0.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sephalin?
The register lists 1 active mandates at Sephalin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sephalin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →